THE CLINICAL APPLICATION OF THE MONOCLONAL ANTIBODIES TARGETED ANTI-CANCER DRUGS IN ZHONGSHAN HOSPITAL
10.3969/j.issn.1671-332X.2015.04.037
- VernacularTitle:中山市某三甲医院单抗类抗肿瘤药应用分析
- Author:
Ruomei XIAO
;
Chuxin LIAO
;
Guifeng WANG
- Publication Type:Journal Article
- Keywords:
Monoclonal Antibodies;
Targeted Anticancer Drugs;
Medical Records Analysis
- From:
Modern Hospital
2015;(4):93-96
- CountryChina
- Language:Chinese
-
Abstract:
Objective To know the current situation of the Monoclonal antibodies target anticancer drugs by collecting and analyzing data,to provide reference for the clinical reasonable application .Methods We collected 310 cases used the antibodies target anticancer drugs in the hospital of ZhongShan , analyzed its clinical efficacy, and evaluated the drugs'efficacy combining the time be hospitalized .Results The sum and number of charges of the Monoclonal antibodies targeted anticancer drugs are 13.67 percent and 0.12 percent in the total charges of anticancer drugs.There are 241 cases (78%) hospitalized in a single course of treatment within 14 days; 298(96%) comple-ted the chemotherapy successfully .Conclusion The monoclonal antibodies targeting anticancer drugs has the good clinical efficacy, and most of the adverse reactions are mild or moderate which can recover after treated .The key fac-tor limited the clinical application of the monoclonal antibodies targeted anticancer drugs is the price .
